Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 26, 2026, titled ""At the ASCOr 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT (cosibelimab-ipdl)"".